Metlife Inc (NYSE:MET) – Equities research analysts at Langen Mcalenn decreased their Q4 2017 earnings per share (EPS) estimates for Metlife in a research report issued to clients and investors on Tuesday. Langen Mcalenn analyst L. Greenberg now forecasts that the financial services provider will post earnings per share of $1.10 for the quarter, down from their previous forecast of $1.12.
Other analysts have also issued research reports about the stock. TheStreet upgraded shares of Metlife from a “c+” rating to a “b” rating in a research note on Wednesday, October 4th. ValuEngine lowered shares of Metlife from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 10th. Argus lifted their price objective on shares of Metlife from $55.00 to $60.00 and gave the company a “buy” rating in a research note on Monday, November 6th. Wells Fargo & Co restated a “buy” rating on shares of Metlife in a research note on Wednesday, October 18th. Finally, Zacks Investment Research upgraded shares of Metlife from a “hold” rating to a “buy” rating and set a $60.00 price target for the company in a research note on Thursday, November 9th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $57.90.
Metlife (NYSE:MET) last released its quarterly earnings data on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.19. The company had revenue of $16.10 billion during the quarter, compared to analyst estimates of $15.47 billion. Metlife had a negative net margin of 0.75% and a positive return on equity of 8.81%. Metlife’s revenue for the quarter was up 1.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.28 EPS.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 13th. Shareholders of record on Monday, February 5th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, February 2nd. This represents a $1.60 dividend on an annualized basis and a yield of 3.04%. Metlife’s dividend payout ratio (DPR) is presently 347.83%.
In other Metlife news, insider Christopher G. Townsend sold 55,712 shares of Metlife stock in a transaction on Monday, November 6th. The shares were sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the transaction, the insider now directly owns 25,181 shares of the company’s stock, valued at approximately $1,367,076.49. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Christopher G. Townsend sold 82,731 shares of Metlife stock in a transaction on Friday, November 3rd. The stock was sold at an average price of $54.60, for a total transaction of $4,517,112.60. Following the transaction, the insider now directly owns 49,660 shares in the company, valued at $2,711,436. The disclosure for this sale can be found here. Insiders own 0.32% of the company’s stock.
Institutional investors and hedge funds have recently bought and sold shares of the business. Farmers National Bank purchased a new position in Metlife during the 2nd quarter worth $118,000. Ffcm LLC boosted its holdings in Metlife by 2,020.8% during the 3rd quarter. Ffcm LLC now owns 2,248 shares of the financial services provider’s stock worth $119,000 after acquiring an additional 2,142 shares during the last quarter. Cable Hill Partners LLC boosted its holdings in Metlife by 246.6% during the 3rd quarter. Cable Hill Partners LLC now owns 2,412 shares of the financial services provider’s stock worth $125,000 after acquiring an additional 1,716 shares during the last quarter. Valeo Financial Advisors LLC purchased a new position in Metlife during the 3rd quarter worth $151,000. Finally, Fieldpoint Private Securities LLC purchased a new position in shares of Metlife in the 3rd quarter worth about $175,000. 76.27% of the stock is currently owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION NOTICE: This news story was first published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of U.S. & international copyright legislation. The original version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3143937/langen-mcalenn-comments-on-metlife-incs-q4-2017-earnings-met.html.
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.